This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK, July 24, 2013 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that trading of Heat Biologics (Nasdaq:HTBX), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies, commenced on The NASDAQ Stock Market on July 24, 2013 under the ticker symbol "HTBX."
Heat Biologics is a clinical-stage company focused on developing its proprietary
ImPACT Therapy to combat a wide variety of cancers.
ImPACT elicits powerful immune response within a patient by exploiting the natural ability of antigens to activate the immune system. Heat Biologics will use the proceeds of the IPO to fund its Phase II clinical trials against lung cancer and plans to initiate additional clinical trials against bladder cancer later this year.
"Heat Biologics is a groundbreaking company and committed to applying its proprietary
ImPACT technology to treat a wide range of cancers," said Nelson Griggs, Senior Vice President, NASDAQ OMX Corporate Client Group. "We are pleased to welcome Heat Biologics to The NASDAQ Stock Market, and look forward to supporting them as a public company for many years."
NASDAQ OMX has consistently been the exchange of choice for progressive and cutting-edge health care companies like PTC Therapeutics, Portola Pharmaceuticals Inc., Chimerix Inc. and bluebird bio, Inc. Year-to-date in 2013, NASDAQ OMX has welcomed over 90 percent of the health care companies that have listed on U.S. markets.
About NASDAQ OMX:
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-40 microsecond speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit
nasdaqomx.com. Follow us on Facebook (
http://www.facebook.com/NASDAQ ) and Twitter (
http://www.twitter.com/nasdaqomx ). (Symbol: NDAQ and member of S&P 500)
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding NASDAQ-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
- NDAQG -
CONTACT: NASDAQ OMX Media Contact: